Jump Financial, LLC Revance Therapeutics, Inc. Transaction History

Jump Financial, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 21, 2024	SELL	$11.47 - $25.07 $1.27 Million - $2.78 Million	-110,945 Reduced 85.96%	18,122 $207,000
Q3 2023 Nov 07, 2023	SELL	$11.47 - $25.07 $1.27 Million - $2.78 Million	-110,945 Reduced 85.96%	18,122 $207,000
Q2 2023 Oct 21, 2024	BUY	$24.7 - $37.61 $3.19 Million - $4.85 Million	129,067 New	129,067 $3.27 Million
Q2 2023 Aug 07, 2023	BUY	$24.7 - $37.61 $3.19 Million - $4.85 Million	129,067 New	129,067 $3.27 Million
Q4 2022 Feb 13, 2023	SELL	$18.32 - $30.66 $97,041 - $162,406	-5,297 Reduced 7.77%	62,903 $1.16 Million
Q3 2022 Nov 07, 2022	SELL	$14.33 - $28.47 $23,529 - $46,747	-1,642 Reduced 2.35%	68,200 $1.84 Million
Q2 2022 Aug 09, 2022	BUY	$11.52 - $20.4 $804,579 - $1.42 Million	69,842 New	69,842 $966,000
Q4 2020 Feb 12, 2021	SELL	$23.41 - $28.34 $429,924 - $520,464	-18,365 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$23.23 - $34.3 $426,618 - $629,919	18,365 New	18,365 $462,000

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.